News
Cosmos Holdings Achieves Positive Adjusted Net Income and Positive Adjusted EBITDA for the Third Quarter of 2021
Cosmos Holdings Achieves Positive Adjusted Net Income and Positive Adjusted EBITDA for the Third Quarter of 2021 November 16, 2021 09:15 ET http://schema.org/Organization">| Source: Cosmos Holdings     CHICAGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today provided a business update and reported financial results for the third quarter ended September 30, 2021. Greg Siokas, Chief Executive Officer of Cosmos Holdings, stated, ...
Cosmos Holdings Announces Installation of State-of-the-Art Automated Fulfillment System to Maximize the Productivity of CosmoFarm’s Pharmaceutical Logistic Center in Athens, Greece
Cosmos Holdings Announces Installation of State-of-the-Art Automated Fulfillment System to Maximize the Productivity of CosmoFarm’s Pharmaceutical Logistic Center in Athens, Greece November 15, 2021 09:11 ET http://schema.org/Organization">| Source: Cosmos Holdings   CHICAGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced that it has integrated SSI SCHAEFER’s A-Frame Automated Robotic Picking System (“A-Frame”) into their pharmaceutical logistic center, CosmoFarm, a ...
Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings
Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings Received initial bridge financing for proceeds of approximately $500,000 plus an additional $5.0 million of Series A Preferred Stock upon approval of Nasdaq listing September 21, 2021 11:50 ET http://schema.org/Organization">| Source: Cosmos Holdings   CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, through an extensive, established European Union distribution network, ...
Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet
Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet   CHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, and an extensive, established European Union distribution network, today announced that the Company has entered into a debt exchange agreement with its senior lender (Lender) to further reduce the Company’s debt. Under the ...
Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021
Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021   CHICAGO, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, today provided a business update and reported financial results for the second quarter ended June 30, 2021. Greg Siokas, Chief Executive Officer of Cosmos Holdings, stated, "I am pleased to report ...
Photo
David E. Gutierrez
Head of PR, IR
and Corporate Development

Join our mailing list to stay up to date.

Cosmos-logo